Molecular biological features of cyst wall of adamantinomatous craniopharyngioma

Zhao Chuan, Ye Wang, Hongxing Liu, Xueling Qi, Zhongqing Zhou, Xianlong Wang, Zhixiong LinScientific 2023 · DOI

Abstract

The molecular biological differences between cyst walls and solid bodies in adamantinomatous craniopharyngioma (ACP) are critical to understanding clinical outcomes. In this study, CTNNB1 mutations were confirmed by DNA sequencing, and expression levels were detected via PCR. Differences in proliferative capacity and tumor stem cell niches between solid bodies and cyst walls were assessed by immunohistochemistry, while the effect of residual cyst wall on recurrence was evaluated through clinical follow-up. Mutations in CTNNB1 were identical in both the cyst wall and solid body for each case. However, the cyst wall exhibited a significantly stronger proliferative capacity ($P = 0.0021$) and a higher concentration of $\beta$-catenin nuclear-positive cell clusters ($P = 0.0002$) compared to the solid tumor. Retrospective analysis of 45 ACP cases showed that residual cyst wall was significantly associated with tumor recurrence ($P = 0.0176$). These findings suggest that the cyst wall of ACP contains more tumor stem cell niches, necessitating special surgical attention to its complete management.

Introduction

Adamantinomatous craniopharyngioma (ACP) is a challenging, slow-growing brain tumor typically found in the sellar region. These tumors are characterized by a complex architecture consisting of solid, calcified masses and large, fluid-filled cysts. Surgeons have long observed a clinical "mystery": patients undergoing subtotal resection (STR) where a small piece of the cyst wall is left behind experience much higher recurrence rates than those where a portion of the solid tumor remains.

Figure 1: Clinical and intraoperative imaging of ACP. CT (a) and MRI (b-e, g-h) show the cystic component (blue arrows) and solid component (red arrowheads). Intraoperative views (f, i) highlight the cyst wall and solid body.

Until now, it was unclear if the cyst wall was biologically distinct or merely a compressed version of the solid tumor. This study defines the molecular and pathological features of the cyst wall to provide a theoretical basis for more aggressive surgical management, shifting the view of the cyst wall from a mere "container" to a highly active reservoir of tumor stem cells.

Methods

The researchers conducted a multi-modal analysis comparing matched samples of cyst walls and solid tumor bodies from 11 patients, with normal brain tissue as a control. The methodology included:

  • Genomic and Transcriptional Analysis: Whole exome sequencing (WES) and Sanger sequencing were used to identify mutations in the CTNNB1 gene, while real-time PCR measured mRNA expression levels.
  • Protein Expression and Proliferation: Immunohistochemistry (IHC) for Ki67 (a marker of cell division) and $\beta$-catenin (to identify characteristic "cell clusters") was performed.
  • Stem Cell Identification: Double immunofluorescence staining for CD44 and $\beta$-catenin was utilized to locate tumor stem cell niches.
  • Clinical Correlation: A retrospective analysis of 45 ACP cases correlated surgical outcomes (Gross Total Resection vs. Subtotal Resection) with long-term recurrence data (follow-up of 3 to 43 months).

Key Results

Genetic Identity vs. Phenotypic Difference

While CTNNB1 mutations were identical in both the cyst wall and the solid body of individual patients, their biological behavior differed significantly. The cyst wall represents a distinct, more aggressive state of the tumor rather than a different tumor type.

Proliferative Drive and Stem Cell Niches

The Ki67 labeling index—a proxy for cell division—was significantly higher in the cyst wall (median 16%) compared to the solid body (median 3%, $P = 0.0021$). Most importantly, the study identified that tumor stem cell niches (nuclear $\beta$-catenin and CD44 positive clusters) are significantly more abundant in the cyst wall.

Figure 6: Double immunofluorescence staining for β-catenin (green) and CD44 (red) with DAPI (blue) nuclear staining. The merged images show a higher density of stem cell niches (cell clusters) in the cyst wall compared to the solid body.

The percentage of $\beta$-catenin nuclear-positive cell clusters was vastly higher in the cyst wall (median 34.60%) than in the solid body (median 4.20%, $P = 0.0002$). This suggests the cyst wall acts as a concentrated reservoir of "seeds" for tumor regrowth.

Clinical Impact on Recurrence

Retrospective analysis confirmed that residual cyst wall was significantly associated with tumor recurrence or regrowth ($P = 0.0176$). Kaplan–Meier analysis demonstrated a stark difference in progression-free survival between Gross Total Resection (GTR) and Subtotal Resection (STR) ($P < 0.0001$), emphasizing that leaving any part of the wall behind is a major risk factor for the patient.

Conclusion

The cyst wall of ACP is the "invasive front" of the tumor. Its proximity to vital structures like the optic chiasm makes complete removal difficult, yet its high concentration of stem cell niches makes that removal essential to prevent recurrence. Future work may explore targeted therapies or specialized radiotherapy to address the radioresistance of these stem cell niches, which may be more accessible within the thin cyst wall than in the dense solid tumor body.

Summary updated

Abstract

The molecular biological differences between cyst walls and those in solid bodies are the foundation of the outcomes. In this study, the CTNNB1 mutations were confirmed by DNAsequencing; CTNNB1 expression levels were detected by PCR; the differences between solid bodies and cyst walls in proliferative capacity and tumor stem cell niches were assessed by immunohistochemistry; the effect of the residual cyst wall on recurrence was assessed by follow-up. Mutations in the CTNNB1 in the cyst wall and the solid body were identical in each case. No differences were found in the transcriptional level of CTNNB1 between the cyst walls and the solid bodies (P = 0.7619). The cyst wall showed a pathological structure similar to the solid body. Proliferative capacity of cyst walls was stronger than that of solid body (P = 0.0021), and β-catenin nuclear positive cells (cell clusters) in cyst walls were more than that in solid tumor (P = 0.0002). The retrospective 45 ACPs showed residual cyst wall was significantly associated with tumor recurrence or regrowth (P = 0.0176). Kaplan-Meier analysis showed there was a significant difference in the prognosis between GTR and STR (P < 0.0001).The cyst wall of ACP contained more tumor stem cell niches which could lead to the recurrence. According to the above-mentioned, a special attention to the management of the cyst wall should be paid.
BibTeX
@inproceedings{chuan2023molecular,
  author = {Zhao Chuan and Ye Wang and Hongxing Liu and Xueling Qi and Zhongqing Zhou and Xianlong Wang and Zhixiong Lin},
  title = {{Molecular biological features of cyst wall of adamantinomatous craniopharyngioma}},
  booktitle = {Scientific},
  year = {2023},
  doi = {10.1038/s41598-023-29664-z},
}
Figure